HK1127998A1 - 含有氧化不穩定組分的穩定的眼用組合物 - Google Patents

含有氧化不穩定組分的穩定的眼用組合物

Info

Publication number
HK1127998A1
HK1127998A1 HK09105622.6A HK09105622A HK1127998A1 HK 1127998 A1 HK1127998 A1 HK 1127998A1 HK 09105622 A HK09105622 A HK 09105622A HK 1127998 A1 HK1127998 A1 HK 1127998A1
Authority
HK
Hong Kong
Prior art keywords
ophthalmic compositions
unstable components
oxidatively unstable
stabilized ophthalmic
stabilized
Prior art date
Application number
HK09105622.6A
Other languages
English (en)
Inventor
Shivkumar Mahadevan
Frank Molock
Original Assignee
Johnson And Johnson Vision Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson And Johnson Vision Care Inc filed Critical Johnson And Johnson Vision Care Inc
Publication of HK1127998A1 publication Critical patent/HK1127998A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK09105622.6A 2006-03-17 2009-06-23 含有氧化不穩定組分的穩定的眼用組合物 HK1127998A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78355706P 2006-03-17 2006-03-17
PCT/US2007/064142 WO2007109523A2 (en) 2006-03-17 2007-03-16 Stabilized ophthalmic compositions comprising oxidatively unstable components

Publications (1)

Publication Number Publication Date
HK1127998A1 true HK1127998A1 (zh) 2009-10-16

Family

ID=38421691

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09105622.6A HK1127998A1 (zh) 2006-03-17 2009-06-23 含有氧化不穩定組分的穩定的眼用組合物
HK09108411.5A HK1132176A1 (zh) 2006-03-17 2009-09-14 用於使氧化不穩定的組合物穩定的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK09108411.5A HK1132176A1 (zh) 2006-03-17 2009-09-14 用於使氧化不穩定的組合物穩定的方法

Country Status (13)

Country Link
US (4) US8466174B2 (zh)
EP (1) EP2010143B1 (zh)
JP (1) JP5275214B2 (zh)
KR (3) KR20140083056A (zh)
CN (1) CN101420934B (zh)
AR (1) AR059927A1 (zh)
AU (1) AU2007227091B2 (zh)
BR (1) BRPI0709549A2 (zh)
CA (2) CA2908828C (zh)
HK (2) HK1127998A1 (zh)
RU (2) RU2462234C2 (zh)
TW (1) TWI454286B (zh)
WO (1) WO2007109523A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA016221B1 (ru) 2006-03-31 2012-03-30 ВИСТЭКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи Офтальмические композиции и способ лечения аллергических заболеваний глаз
AR059928A1 (es) 2006-09-29 2008-05-07 Johnson & Johnson Vision Care Metodos y dispositivos oftalmicos usados en el tratamiento de alergias oculares
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
IT1393419B1 (it) * 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
JP5675183B2 (ja) * 2009-06-16 2015-02-25 ロート製薬株式会社 水性組成物
US20120225918A1 (en) 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
CN108348516B (zh) * 2015-10-29 2021-02-12 特一华制药株式会社 外用剂
BR112020018377A2 (pt) 2018-03-09 2021-03-09 Portola Pharmaceuticals, Inc Métodos de uso e composições farmacêuticas de um inibidor de syk seletivo
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304762A (en) * 1978-09-27 1981-12-08 Lever Brothers Company Stabilization of hydrogen peroxide
DD150694A1 (de) * 1980-04-16 1981-09-16 Gisela Raether Verfahren zur stabilisierung von pharmazeutischen praeparaten mit oxidationsempfindlichen bestandteilen
DE3640708C2 (de) * 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
ES2091204T3 (es) * 1988-08-04 1996-11-01 Ciba Geigy Ag Metodo y composiciones para conservar soluciones oftalmicas.
US5514732A (en) * 1993-07-22 1996-05-07 Johnson & Johnson Vision Products, Inc. Anti-bacterial, insoluble, metal-chelating polymers
WO1995025518A1 (en) 1994-03-18 1995-09-28 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
JPH07324034A (ja) 1994-05-30 1995-12-12 Toa Yakuhin Kk フマル酸ケトチフェン含有の点眼剤
US5683993A (en) 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
US6020373A (en) * 1995-10-20 2000-02-01 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury
RU2140236C1 (ru) * 1996-08-20 1999-10-27 Хабаровский филиал МНТК "Микрохирургия глаза" Способ лечения диабетической ретинопатии
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
JPH11189528A (ja) * 1997-12-26 1999-07-13 Lead Chemical Co Ltd 安定性の改善された皮膚適用製剤
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
JPH11279205A (ja) * 1998-03-26 1999-10-12 Nippon Tenganyaku Kenkyusho:Kk ヒアルロン酸類製剤の分解抑制方法
DK1098649T3 (da) 1998-04-02 2004-10-04 Novartis Ag Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant
JP2002520355A (ja) 1998-07-14 2002-07-09 アルコン ラボラトリーズ， インコーポレイテッド 非アレルギー性眼炎症障害を処置および眼新生血管形成を予防する医薬製造のための、１１−（３−ジメチルアミノプロピリデン）−６，１１−ジヒドロジベンズ［ｂ，ｅ］オキセピン−２−酢酸の使用
US6395756B2 (en) 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent
RU2196594C2 (ru) * 2000-09-25 2003-01-20 Общество с ограниченной ответственностью "Камелия НПП" Средство, обладающее восстановительным, тонизирующим и регенераторным действием
JP2004509925A (ja) * 2000-09-28 2004-04-02 ノバルティス　アクチエンゲゼルシャフト 安定化過酸化水素溶液
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
RU2191012C1 (ru) * 2001-06-20 2002-10-20 Научно-исследовательский испытательный центр (медико-биологической защиты) Государственного научно-исследовательского испытательного института военной медицины МО РФ Глазные капли для лечения эндотелиально-эпителиальной дистрофии роговицы
RU2201213C1 (ru) * 2001-07-04 2003-03-27 Общество с ограниченной ответственностью "Научно-экспериментальное производство Микрохирургия глаза" Глазные капли "карнозин"
JP4436131B2 (ja) * 2001-11-21 2010-03-24 イオルテク ヒアルロン酸を安定化させる組成物
AR038299A1 (es) 2002-01-18 2005-01-12 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas.
AU2003297511B2 (en) * 2002-12-20 2010-01-21 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
US20050244509A1 (en) * 2004-03-17 2005-11-03 Fu-Pao Tsao Ophthalmic solutions
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
AR059928A1 (es) * 2006-09-29 2008-05-07 Johnson & Johnson Vision Care Metodos y dispositivos oftalmicos usados en el tratamiento de alergias oculares

Also Published As

Publication number Publication date
CA2908828C (en) 2018-01-16
CN101420934B (zh) 2014-03-19
KR20140083056A (ko) 2014-07-03
JP2009530314A (ja) 2009-08-27
KR20150017002A (ko) 2015-02-13
WO2007109523A3 (en) 2008-04-10
BRPI0709549A2 (pt) 2011-07-19
EP2010143B1 (en) 2015-08-12
TWI454286B (zh) 2014-10-01
HK1132176A1 (zh) 2010-02-19
CA2646424C (en) 2015-12-29
US20170007592A1 (en) 2017-01-12
CA2908828A1 (en) 2007-09-27
RU2012125612A (ru) 2013-12-27
US20180050026A1 (en) 2018-02-22
US20140011843A1 (en) 2014-01-09
AU2007227091A1 (en) 2007-09-27
RU2008141172A (ru) 2010-04-27
KR20080111065A (ko) 2008-12-22
EP2010143A2 (en) 2009-01-07
KR101454674B1 (ko) 2014-10-27
RU2462234C2 (ru) 2012-09-27
AR059927A1 (es) 2008-05-07
US20070265234A1 (en) 2007-11-15
CN101420934A (zh) 2009-04-29
US9474746B2 (en) 2016-10-25
CA2646424A1 (en) 2007-09-27
JP5275214B2 (ja) 2013-08-28
US8466174B2 (en) 2013-06-18
WO2007109523A2 (en) 2007-09-27
TW200808355A (en) 2008-02-16
AU2007227091B2 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
HUS2000015I1 (hu) Fungicid készítmények
HK1132176A1 (zh) 用於使氧化不穩定的組合物穩定的方法
ZA200808773B (en) Stable emulsion formulations
EP2040708A4 (en) CROSS-CONTAINING COMPOSITIONS
EP2124575A4 (en) ANTIMICROBIAL COMPOSITIONS
EP1906776A4 (en) TOBACCO COMPOSITIONS
GB0621023D0 (en) Fragrance compositions
HK1134245A1 (en) Multiple emulsion compositions
IL243457B (en) Cyclopropane preparations
GB0625069D0 (en) Compositions
GB0501192D0 (en) Stable prostaglandin-containing compositions
IL186673A0 (en) Stable emulsion composition
GB0620279D0 (en) Compositions
IL197927A0 (en) W/o/w emulsion composition
GB0615213D0 (en) Fungicidal compounds and compositions
GB0618657D0 (en) Compositions
EP1986849A4 (en) COMBUSTION REMOVAL COMPOSITIONS, RESISTANT TO WASH
GB0615583D0 (en) Perfume compositions
GB0621020D0 (en) Fragrance compositions
GB0615580D0 (en) Perfume compositions
SG131101A1 (en) Methods for providing oxidatively stable ophthalmic compositions
EP1894565A4 (en) STABILIZED MILNACIPRANE FORMULATION
PT1865051T (pt) Composições de branqueamento
GB0620918D0 (en) Compositions
EP2061445A4 (en) ANTIMICROBIAL COMPOSITIONS